<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="364326">
  <stage>Registered</stage>
  <submitdate>28/05/2013</submitdate>
  <approvaldate>31/05/2013</approvaldate>
  <actrnumber>ACTRN12613000626763</actrnumber>
  <trial_identification>
    <studytitle>Cocoa for cognitive function, mood and cardiovascular function: acute and cumulative effect in younger adults.</studytitle>
    <scientifictitle>The acute and cumulative effect of high-flavanol cocoa vs placebo on cognitive function, mood and cardiovascular function in healthy adults aged 18-40 years: a randomised double-blind placebo-controlled one month trial</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>None</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Cognitive function</healthcondition>
    <healthcondition>Cardiovascular function</healthcondition>
    <healthcondition>Mood</healthcondition>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Studies of the normal brain and nervous system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Normal development and function of the cardiovascular system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Participants will take one tablet of a cocoa supplement (containing 250 mg polyphenols) after baseline assessment &amp; assessment 2 hours after ingestion (acute) and one tablet of cocoa supplement daily for 4 weeks (cumulative).

Calendars including trial information will be provided to patients at baseline. To assess compliance, patients will be instructed to mark each day when they have taken the trial capsules, and bring the calendar and any remaining trial capsules to their next appointment.</interventions>
    <comparator>Placebo tablet</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Cognitive function: 
1. By computerised standardised validated assessement battery: SUCCAB (Swinburne University Computerised Cognitive Ageing Battery) containing 7 tasks (e.g. simple reaction time, spatial working memory), and takes about 25 minutes
2. Cognitive Demand Battery: Consists of two computerised serial subtraction tasks (serial threes and serial sevens) and takes about 10 minutes</outcome>
      <timepoint>2 hours after ingestion of trial tablet compared with baseline</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Mood: Assessment by questionnaire
1. Visual Analog Mood Scale (Bond &amp; Lander 1974)
2. State Trait Anxiety Inventory (Spielberger 1969)</outcome>
      <timepoint>2 hours after ingestion of trial tablet compared with baseline</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Cognitive function
1. By computerised standardised validated assessement battery: SUCCAB (Swinburne University Computerised Cognitive Ageing Battery) containing 7 tasks (e.g. simple reaction time, spatial working memory), and takes about 25 minutes
2. Cognitive Demand Battery: Consists of two computerised serial subtraction tasks (serial threes and serial sevens) and takes about 10 minutes

Mood
1. Visual Analog Mood Scale (Bond &amp; Lander 1974)
2. State Trait Anxiety Inventory (Spielberger 1969)</outcome>
      <timepoint>4 weeks after baseline</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cardiovascular function:
1. Blood pressure using a Sphymomanometer
2. Arterial stiffness and central blood pressure using SphymoCor Tonometer
</outcome>
      <timepoint>2 hours after ingestion of trial tablet compared with baseline</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cardiovascular function
1. Blood pressure using a Sphymomanometer
2. Arterial stiffness and central blood pressure using SphymoCor Tonometer
</outcome>
      <timepoint>4 weeks after baseline</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy between 18-40 years of age</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>1. Poor comprehension of written and spoken English
2. Psychiatric disorder
3. Suffering from endocrine or gastrointestinal disorders
4. Pregnant or lactating
5. Taking antidepressants, antipsychotics, anxiolytics, illicit drugs or any cognitive enhancing drugs
6. Undergoing participation in another study
7. Suffer from colour blindness or any other severe visual impairment
8. Taking anti-coagulants or have bleeding disorders
</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Consenting volunteers will be allocated to either cocoa or placebo tablets. Cocoa and placebo tablets are matched in size and appearance and are packaged in identical containers labelled with the ID and study identifier.</concealment>
    <sequence>A computer-generated permuted block randomisation schedule will be used to allocate patients to cocoa or placebo-control groups. Randomisation will be done by a statistical consultant not involved in allocation of treatment to the participants.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods>A sample size of 40 participants (20 in each group) is calculated based on the following assumptions: 
a) To detect a difference of 12 +/- 3 mm on the VAS Mental fatigue scale as part of the Cognitive Demand Battery after 10 min of consuming an acute dose of a cocoa product  containing 520 mg of cocoa flavanols had 30 participants in a three week period crossover design (scholey 2010) with a power of 80% and 95% confidence
b) To account for 20% drop-out or non-attendance at all appointments</statisticalmethods>
    <masking1>True</masking1>
    <masking2>True</masking2>
    <masking3>True</masking3>
    <masking4>True</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2</phase>
    <anticipatedstartdate>17/06/2013</anticipatedstartdate>
    <actualstartdate>19/08/2013</actualstartdate>
    <anticipatedenddate>31/10/2014</anticipatedenddate>
    <actualenddate>30/10/2015</actualenddate>
    <samplesize>40</samplesize>
    <actualsamplesize>40</actualsamplesize>
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <postcode>3122 - Hawthorn</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>National Institute of Integrative Medicine</primarysponsorname>
    <primarysponsoraddress>759 Burwood Rd
Hawthorn East VIC 3123</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Participant vouchers:
Discipline of General Practice, The University of Adelaide</fundingname>
      <fundingaddress>Level 11, 178 North Tce
Adelaide, SA 5005</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>Swinburne University of Technology</sponsorname>
      <sponsoraddress>Burwood Rd
Hawthorn VIC 3122</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Study aims to investigate the effects of acute and cumulative doses of high-flavanol cocoa on cognitive function, mood, and cardiovascular health in a group of healthy younger adults. </summary>
    <trialwebsite />
    <publication>Massee LA, Ried K, Pase M et al. The acute and sub-chronic effects of cocoa flavanols on mood, cognitive and cardiovascular health in young healthy adults: and RCT. Frontiers in Pharmacology 2015, 6: 93</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Swinburne University Human Research Ethics Committee</ethicname>
      <ethicaddress>Burwood Rd
Hawthorn VIC 3122</ethicaddress>
      <ethicapprovaldate>26/04/2013</ethicapprovaldate>
      <hrec>SUHREC 2013/058</hrec>
      <ethicsubmitdate>26/03/2013</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Karin Ried</name>
      <address>National Institute of Integrative Medicine
759 Burwood Rd
Hawthorn East VIC 3123</address>
      <phone>+61 3 9804 0646</phone>
      <fax />
      <email>karinried@niim.com.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Karin Ried</name>
      <address>National Institute of Integrative Medicine
759 Burwood Rd
Hawthorn East VIC 3123</address>
      <phone>+61 3 9804 0646</phone>
      <fax />
      <email>karinried@niim.com.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Karin Ried</name>
      <address>National Institute of Integrative Medicine
759 Burwood Rd
Hawthorn East VIC 3123</address>
      <phone>+61 3 9804 0646</phone>
      <fax />
      <email>karinried@niim.com.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Karin Ried</name>
      <address>National Institute of Integrative Medicine
759 Burwood Rd
Hawthorn East VIC 3123</address>
      <phone>+61 3 9804 0646</phone>
      <fax />
      <email>karinried@niim.com.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>